Streptozocin

Streptozocin is an anti-cancer medication used to treat certain kinds of pancreatic and other kinds of cancer, such as islet cell carcinoma and metastatic cancer. It works by destroying cancer cells and slowing their growth. The medicine is given intravenously, usually as part of a combination therapy. Common side effects include nausea, vomiting, fever, and diarrhea. Less common side effects include kidney damage, anemia, and low white blood cell counts.

Streptozocin is a medication with interesting and important, but also complex, uses in medicine. Here's a breakdown of its key aspects:

What it is:

  • A naturally occurring antibiotic produced by the bacteria Streptomyces achromogenes.
  • Classified as a nitrosourea antineoplastic agent, meaning it has anti-cancer properties.

What it does:

  • Acts in two main ways:
    • Antineoplastic effect: Damages the DNA of cancer cells, hindering their growth and division.
    • Diabetogenic effect: Selectively destroys insulin-producing beta cells in the pancreas, which can be useful for research purposes but is a side effect to avoid during treatment.

Medical uses:

  • Primarily used to treat metastatic pancreatic islet cell carcinoma: This is a rare form of cancer that develops in the hormone-producing cells of the pancreas. Streptozocin is often used in combination with other chemotherapy drugs.
  • Research: Due to its ability to induce diabetes in animals, it's used in research to create models for studying diabetes and other conditions.

Important considerations:

  • Strong side effects: Streptozocin can cause serious side effects, including kidney damage, hearing loss, and allergic reactions.
  • Limited use: Due to the risk of side effects and the availability of other treatments, its use is generally reserved for situations where surgery is not an option.
  • Not a cure: Streptozocin can help shrink tumors and alleviate symptoms, but it typically doesn't cure pancreatic cancer.
     
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L01 Antineoplastic agents
L01A - Alkylating agents
L01AD Nitrosoureas
External Links